Browse > Article
http://dx.doi.org/10.4333/KPS.2005.35.5.329

In vitro and In vivo Evaluation of Novel Gel Formulations of Testosterone for Transdermal Delivery  

Heo, Sung-Koun (College of Pharmacy, Pusan National University)
Cho, Young-Seok (Dong Sung Pharm. Co., Ltd.)
Han, Sang-Dae (Dong Sung Pharm. Co., Ltd.)
Chang, Jin-Kang (Dong Sung Pharm. Co., Ltd.)
Yoon, Eun-Ju (Dong Sung Pharm. Co., Ltd.)
Ko, Dae-Woong (Dong Sung Pharm. Co., Ltd.)
Lim, Chang-Baeg (Dong Sung Pharm. Co., Ltd.)
Chung, Suk-Jae (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Shim, Chang-Koo (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Kim, Dae-Duk (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Publication Information
Journal of Pharmaceutical Investigation / v.35, no.5, 2005 , pp. 329-332 More about this Journal
Abstract
HPMC-based novel gel formulations for the transdermal delivery of testosterone (TS) were developed, and the effect of various skin permeation enhancers was studied in vitro and in vivo. In vitro hairless mouse skin permeation of TS from the gel was investigated using Keshary-Chien diffusion cells for 8 hours at $37^{\circ}C$. In vivo plasma concentration profiles of TS after applying the gel on the abdominal skin of rat were determined using a commercial radioimmunoassay kit. Hairless mouse skin permeation of TS increased with the addition of permeation enhancers both in vitro and in vivo. Combination of diethanolamine (2%) and N-methylpyrrolidone (NMP, 6%) was the most effective among tested. Plasma concentration of TS significantly increased for at least 24 hours with the addition of diethanolamine and NMP. These results suggest the feasibility of the development of a HPMC-based gel formulation for the transdermal delivery of TS.
Keywords
Testosterone; Permeation enhancer; Pharmacokinetics; Transdermal delivery; Gel;
Citations & Related Records
연도 인용수 순위
  • Reference
1 J.G. Hardman and L.E. Limbird, A Goodman and Gilman's the pharmacological basis of therapeutics, 9th ed., Macmillan, London, pp. 1459-1485 (1996)
2 R.L. Rosenfield, Role of androgens in growth and development of the fetus, child, and adolescent. Adv. Pediatr., 19, 172-213 (1972)
3 B.J. Anungst, J.A. Blake and M.A. Hussain, Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res., 7, 712-718 (1990)   DOI   ScienceOn
4 P.J. Lee, R. Langer and V.P. Shastri, Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J. Pharm. Sci., 94, 912-917 (2005)   DOI   ScienceOn
5 B. Salehian, C. Wand, G. Alexander, T. Davidson, V. McDonald, N. Berman, R.E. Dudley, F. Zikl and R.S. Verdloff, Pharmacokinetics, bioefficacy and safety of sublingual tesosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate-A clinical research center study. J. Clin. Endocr. Metab., 80(12), 3567-3575 (1995)   DOI
6 N.M. An, D, D. Kim, Y.H. Shin and C.H. Lee, Development of a novel soft hydrogel for the transdermal delivery of testosterone. Drug Devel. Ind. Pharm., 29, 99-105 (2003)   DOI   ScienceOn
7 A. Koizumi, M. Fujiu, M. Kondoh and Y. Watanabe, Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur. J. Pharm. Biopharm., 57, 473-478 (2004)   DOI   ScienceOn
8 J.E. Royland, L.J. Weber and M. Fitzpatrick, Testes size and testosterone levels in a model for weightlessness. Life Sci., 54, 545-554 (1994)   DOI   ScienceOn
9 A.R. Gennaro, Remington: The Science and Practice of Pharmacy, 20th ed., Lippincott Williams & Wilkins, Philadelphia, U.S.A., pp. 1391 (2000)
10 L. Kikwai, R.J. Babu, N. Kanikkannan and M. Singh, Preformulation stability of Spantide II, a promising topical anti-inflmatory agent for the treatment of psoriasis and contact dermatitis. J. Pharm. Pharmacol., 56, 19-25 (2004)   DOI   ScienceOn
11 S. Satyannrana, S. Ganaga and J. Singh, Transport through rat skin from transdermal patch formulations. Pharmazie, 48, 467-468 (1993)
12 T.M. Morgan, B.L. Reed and B.C. Finnin, Enhanced skin permeation of sex hormones with novel topical spray vehicles. J. Pharm. Sci., 87, 1213-1218 (1998)   DOI
13 T.M. Morgan, R.A. Parr, B.L. Reed and B.C. Finnin, Enhanced transdermal delivery of sex hormones in swine with a novel topical aerosol. J. Pharm. Sci., 87(1), 1219-1225 (1998)   DOI   ScienceOn
14 D.J. Kesler, D.C. Christenson and M.E. Wallace, The effect of esterification on their release of testosterone and estradiol from silicone implants. Drug Dev. Ind. Pharm., 22(3), 275-279 (1996)   DOI
15 A.C. William and B.W. Barry, Skin permeation enhancers. Crit. Rev. Ther. Drug, 9, 305-353 (1992)
16 K. Sugibayashi, S. Nakyama, S. Seki, K. Hosoya and Y. Morimoto, Mechanism of skin penetration-enhancing effect by laurocapram. J. Pharm. Sci., 81, 58-64 (1992)   DOI
17 M.K. Kim, H.Z., C.H. Lee and D.D. Kim, Formulation of a reservoir-type testosterone transdermal delivery system. Int. J. Pharm., 219, 51-59 (2001)   DOI   ScienceOn
18 H.Z., C.H. Lee, S.J. Chung, C.K. Shim and D.D. Kim, In, vitro and in vivo evaluation of a novel non-scrotal matrix-type transdermal delivery system of testosterone. Drug Dev. Ind. Pharm., 31, 257-261 (2005)   DOI
19 M. Fuju, M. Bouno, S. Fujita, M. Yoshida, Y. Watanabe and M. Matsumoto, Preparation of griseofulvin for topical application using N-methyl-2-pyrrolidone. Bio. Pharm. Bull., 23, 1341-1345 (2000)   DOI   ScienceOn